Debiopharm Cancer AI Startup Nucleai Raises $6.5M in Series A Financing The initial investment is led by Debiopharm, which will collaborate with the Israeli startup to accelerate discovery of biomarkers for oncology drug response. Caris Life Sciences Inks CDx Collaboration With Debiopharm Caris will use its whole-transcriptome sequencing assay and Molecular Intelligence Trials service to identify patients for a phase II clinical trial. Primerdesign, GenePOC Partner on Near-Patient Flu/RSV MDx The firms intend to seek CE marking and US Food and Drug Administration clearance for the test. BC Platforms Lands $10 Million Investment From Debiopharm, Tesi wiss genomic data management company BC Platforms seeks to add a clinical component to its existing software this year. GenePOC Instrument, Assays Get CE Mark The firm said that it has completed clinical trials for the Group B Strep assay for the FDA and will start trials for the C. difficile test this month. Sep 1, 2016 GenePOC Gets Additional Debiopharm Investment; on Track to Launch Spinning Disk PCR Platform Premium Jan 9, 2014 Spinomix Receives Milestone Payment from Debiopharm for MDx Sample Prep Tech Premium Jan 9, 2014 People in the News: WaferGen Shuffles Board; Spinomix Names Nahas as CEO Premium Jun 13, 2013 Diagnoplex Using $1.4M Influx to Prep Blood-based Colorectal Cancer Test for CE Mark, 2014 Launch Premium May 23, 2013 Cenix, Debiopharm Ink Biomarker ID Deal May 23, 2013 Cenix to Provide Research Services to Debiopharm Premium Nov 15, 2012 Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina Premium Feb 3, 2011 Lundbeck, Debiopharm Join List of Pharmas Looking to RNAi Premium Feb 3, 2011 Marina Inks Partnership for Bladder Cancer Program Premium Jan 18, 2011 Diagnoplex Gains Financing Extension Apr 28, 2010 Resuscitation Uncertain: Can Debiopharm Help Revive Pfizer's Failed Melanoma Drug? Premium Apr 8, 2010 Biocartis Raises $41.3M, Inks Companion Dx Partnership with Debiopharm Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.